XML 21 R8.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net income $ 5,406 $ 14,862 $ 3,765
Adjustments to reconcile net income to net cash provided by operating activities:      
Accretion of deferred acquisition fees and origination costs 1,757 2,655 1,305
Net interest income accretion on fair value receivables 90,383 26,162 0
Depreciation and amortization 1,076 992 934
Amortization of deferred financing costs 8,281 8,453 8,738
Mark to fair value of finance receivables measured at fair value (2,109) 0 0
Provision for credit losses 85,773 133,080 186,713
Stock-based compensation expense 2,072 3,515 5,715
Changes in assets and liabilities:      
Accrued interest receivable 20,324 14,784 (10,520)
Other assets 7,464 (4,161) 5,361
Deferred tax assets, net 3,708 13,258 10,399
Accounts payable and accrued expenses (7,351) 2,605 3,238
Net cash provided by operating activities 216,784 216,205 215,648
Cash flows from investing activities:      
Originations of finance receivables held for investment 0 0 (859,069)
Payments received on finance receivables held for investment 481,289 605,353 647,619
Purchases of finance receivables measured at fair value (1,004,194) (914,949) 0
Payments on receivables portfolio at fair value 292,948 67,721 4
Change in repossessions held in inventory 1,354 757 1,490
Purchase of furniture and equipment (751) (1,077) (669)
Net cash used in investing activities (229,354) (242,195) (210,625)
Cash flows from financing activities:      
Proceeds from issuance of securitization trust debt 1,000,501 855,828 852,615
Proceeds from issuance of subordinated renewable notes 5,764 3,175 4,083
Payments on subordinated renewable notes (5,520) (2,451) (2,466)
Net proceeds from (repayments of) warehouse lines of credit (1,300) 23,809 9,309
Net advances of residual interest financing debt 0 40,000 0
Repayment of securitization trust debt (966,144) (876,094) (851,193)
Payment of financing costs (8,921) (8,039) (8,104)
Repurchase of common stock (1,440) (5,307) (12,346)
Exercise of options and warrants 352 483 1,085
Net cash provided by (used in) financing activities 23,292 31,404 (7,017)
Increase (decrease) in cash and cash equivalents 10,722 5,414 (1,994)
Cash and cash equivalents at beginning of year 130,110 124,696 126,690
Cash and cash equivalents at end of year 140,832 130,110 124,696
Cash paid (received) during the period for:      
Interest 101,812 92,405 83,110
Income taxes (5,156) 417 9,319
Non-cash financing activities:      
Right-of-use asset, net (21,869) 0 0
Lease liability 23,327 0 0
Deferred office rent $ (1,458) $ 0 $ 0